SMN1 and proximal spinal muscular atrophy: Taken together, these results suggest that analysis of the quantity of SMN protein isolated from serum-derived exosomes, or the concentration of serum-derived exosomes itself, may be a new method to monitor SMA disease or response to therapy in human patients.